PORTOLA VALLEY, Calif.--(BUSINESS WIRE)--Focal Therapeutics announced that its BioZorb™ three-dimensional tissue marker has now been successfully used in over 100 patients – marking a significant milestone for the company and the field of post-surgical radiation treatment for breast cancer.
Help employers find you! Check out all the jobs and post your resume.
